August 29, 2011
Mitsubishi Tanabe Pharma Corporation (MTPC) announced on August 22 that the US Court of Appeals for the Federal Circuit (CAFC) upheld the validity and enforceability of its US patent covering the formulation of its selective antithrombin agent argatroban (US brand...read more